GlassScriptPhysician profile
Austin J Hansen
NPI 1588224703
$7,447.44
in general payments reported to CMS, 2019-2025
42 companies · $1,418 in 2025
The $1,418 reported for 2025 was more than what 85% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7.22 · 2020: $67.55 · 2021: $1,337 · 2022: $2,550 · 2023: $1,473 · 2024: $594 · 2025: $1,418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,485.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,266.00 | 2022-2023 | |
| Aroa Biosurgery Incorporated | $1,044.23 | 2022-2025 | |
| Stryker Corporation | $786.69 | 2020-2025 | Salvation, Alphavent, Inspace |
| Organogenesis INC. | $643.80 | 2021-2022 | |
| Bioventus LLC | $425.36 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Reprise Biomedical, INC. | $363.33 | 2023-2025 | Miro3d |
| Paratek Pharmaceuticals, INC. | $289.41 | 2022-2025 | Nuzyra |
| Abbvie INC. | $251.84 | 2022-2025 | |
| Nevro Corp. | $209.55 | 2023-2024 | Senza |
| Smith+Nephew, INC. | $195.00 | 2021-2025 | Collagenase Santyl, Stravix, Grafix |
| Acumed LLC | $182.45 | 2022 | |
| Globus Medical, INC. | $178.48 | 2025 | Senza |
| Coastal Medical Technologies LLC | $170.15 | 2023-2024 | |
| Boston Scientific Corporation | $168.93 | 2023-2025 | General - Pain Management |
| Linvatec Corporation | $158.16 | 2025 | Biobrace 23mm |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $121.76 | 2022 | |
| Heron Therapeutics, INC. | $121.60 | 2021 | |
| Treace Medical Concepts, INC. | $115.68 | 2024-2025 | |
| Novastep INC. | $87.90 | 2022 | |
| Electronic Waveform Lab, INC. | $68.91 | 2021 | |
| Mvp Orthopedics INC | $64.04 | 2022 | |
| Medtronic, INC. | $51.77 | 2023-2025 | Intellis Adaptivestim, Venaseal, Closurefast |
| Convatec INC. | $48.93 | 2023-2024 | |
| Solventum Corporation | $43.06 | 2024-2025 | Activ.A.C. |
| Vertex Pharmaceuticals Incorporated | $33.73 | 2025 | |
| Kerecis Limited | $32.51 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Djo, LLC | $30.36 | 2025 | Cmf |
| Zimmer Biomet Holdings, INC. | $26.91 | 2021 | |
| Advanced Oxygen Therapy INC. | $25.98 | 2021 | |
| Next Science LLC | $24.77 | 2023 | Blastx, Xperience, Surgx |
| Depuy Synthes Sales INC. | $24.42 | 2024 | Motoband, Minibunion, Motoband Cp |
| Biowound Solutions, INC. | $22.12 | 2025 | Bio-Connekt |
| Orthofix Medical, INC. | $21.28 | 2024 | Accelstim, Physio-Stim |
| Nalu Medical, INC. | $20.58 | 2025 | Nalu Neurostimulation System |
| Biocomposites INC | $19.84 | 2025 | Stimulan |
| Kci USA, INC. | $17.85 | 2023 | Activ.A.C., V.A.C. Dermatac |
| Horizon Therapeutics Plc | $17.85 | 2022 | |
| Amgen INC. | $17.63 | 2024 | Krystexxa |
| Hartmann USA, INC. | $17.57 | 2025 | Zetuvit Plus 10x10 P10 |
| Mimedx Group, INC. | $16.47 | 2025 | |
| Polarityte, INC. | $13.32 | 2020 | |
| Crossroads Extremity Systems, LLC | $7.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.